About

Xiuping Zhang is a leading hepatopancreaticobiliary surgeon whose research focuses on advancing robotic surgery for complex pancreatic and liver procedures. Her major contributions center on demonstrating the safety, feasibility, and oncological efficacy of robotic pancreaticoduodenectomy (RPD) and robotic hepatectomy, particularly through rigorous multicenter, propensity score-matched comparisons with traditional open and laparoscopic approaches. Her landmark 2021 study comparing RPD versus open pancreaticoduodenectomy in low-risk surgical candidates has garnered 75 citations, establishing a benchmark for robotic surgical outcomes. Zhang has also pioneered work on robotic surgery in special populations, including elderly patients and those with large hepatocellular carcinomas, and developed a novel online calculator to predict early recurrence and long-term survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Her cumulative work, spanning over 200 citations, has helped validate robotic approaches as safe alternatives to open surgery, while her first case report of single-port robot-assisted pancreatectomy using the da Vinci SP system showcases her innovative contributions at the frontier of minimally invasive surgical technology.

Research Focus

Key Achievements

8
H-Index
17
Papers
276
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates
75 citations · 2021
📈 Most Prolific Year: 2022 (8 Papers)
🤝 Key Collaborators: 67
🏛 Institutions: Chinese PLA General Hospital, People's Liberation Army No. 150 Hospital, Second Military Medical University, Dana (United States), The 309th Hospital of Chinese People's Liberation Army

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago